New shot for hemophilia a: could marstacimab be a Game-Changer?
NCT ID NCT06703606
First seen Apr 03, 2026 · Last updated May 21, 2026 · Updated 9 times
Summary
This study tests a new medicine called marstacimab for people with severe hemophilia A who want to switch from their current treatment (emicizumab). Hemophilia A is a rare bleeding disorder where blood doesn't clot properly. The study will check if marstacimab is safe and how it works in the body. Participants will receive weekly injections for 4 months, and the study lasts up to 6 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEVERE HEMOPHILIA A are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ege University Faculty of Medicine Dean's Office
RECRUITINGBornova, İzmir, 35100, Turkey (Türkiye)
-
K J Somaiya Hospital & Research Centre
RECRUITINGMumbai, Maharashtra, 400022, India
-
Nirmal Hospital Pvt Ltd.
RECRUITINGSurat, Gujarat, 395002, India
-
Orthopaedic Institute for Children/Orthopaedic Hemophilia Treatment Center
RECRUITINGLos Angeles, California, 90007, United States
Conditions
Explore the condition pages connected to this study.